1.7
Drug-Receptor Bonds
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exe…
Drugs bind their targets or receptors using chemical forces, such as covalent bonds, electrostatic interactions, and hydrophobic effects.
Covalent bonds are strong and irreversible and rarely occur except in toxic situations.
DNA-alkylating anticancer agents form covalent bonds with cancer cells' DNA and arrest their cell division. However, such agents are nonselective and modify the surrounding healthy cells' DNA.
In contrast, non-covalent interactions are weaker but more selective because a drug must precisely fit its target to form such bonds.
Most drugs and receptors interact via electrostatic interactions. Electrostatic interactions are strong between oppositely charged ionized molecules and weak in the case of hydrogen bonds and van der Waals forces.
Another type of weak interaction occurs due to the hydrophobic effect when drugs interact with the internal hydrophobic pockets of receptors and exclude surrounding water molecules.
Such selective interactions of drugs with their receptors modify the activity of target cells without affecting other cells.
View the full transcript and gain access to JoVE Core videos
Q1: What types of chemical forces form drug-receptor bonds?
Drugs bind receptors through three main chemical forces: covalent bonds, electrostatic interactions, and hydrophobic effects. Covalent bonds are strong and irreversible but rarely occur except in toxic situations. Electrostatic interactions range from strong ionic linkages between oppositely charged molecules to weaker hydrogen bonds and van der Waals forces. The hydrophobic effect occurs when lipophilic drugs interact with hydrophobic pockets in receptors, excluding surrounding water molecules.
Q2: Why are covalent drug-receptor bonds considered problematic?
Covalent bonds are strong and irreversible, making them nonselective and potentially toxic. DNA-alkylating anticancer agents exemplify this problem: they form covalent bonds with cancer cell DNA to arrest division, but also indiscriminately modify surrounding healthy cells' DNA. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
Q3: How do noncovalent interactions provide greater drug selectivity?
Noncovalent interactions are weaker than covalent bonds but require a precise fit between drug and target, ensuring selectivity. Most drug-receptor interactions occur through electrostatic interactions, hydrogen bonds, or van der Waals forces. This precise molecular fit allows drugs to modify target cell activity without affecting other cells, making noncovalent interactions ideal for therapeutic drug design.
Q4: What role does the hydrophobic effect play in drug-receptor binding?
The hydrophobic effect occurs when lipophilic drugs interact with hydrophobic pockets within receptors. This interaction excludes surrounding water molecules from the binding site, stabilizing the drug-receptor complex. The hydrophobic effect contributes to selective drug binding by requiring drugs to fit precisely into receptor pockets, preventing nonspecific interactions with other cellular components.
Q5: Why do most therapeutic drugs use noncovalent rather than covalent bonding?
Designing highly selective drugs involves avoiding highly reactive molecules that form covalent bonds and instead opting for weaker bond formation. Noncovalent interactions provide greater selectivity due to the requirement for an exact fit between drug and target. This selectivity allows therapeutic drugs to modify target cell activity without causing widespread tissue damage or affecting healthy cells.
Q6: How do electrostatic interactions differ in strength between drug-receptor pairs?
Electrostatic interactions vary in strength depending on the charges involved. Strong electrostatic interactions occur between oppositely charged ionized molecules, creating stable ionic linkages. Weaker electrostatic interactions include hydrogen bonds and van der Waals forces, which still contribute to selective drug-receptor binding. This range of interaction strengths allows drugs to bind with varying affinities to different receptors.
Q7: What is the relationship between drug selectivity and bond reversibility?
Reversible, noncovalent bonds provide greater selectivity than irreversible covalent bonds because they require precise molecular fit. Covalent bonds are highly reactive but lack selectivity, binding indiscriminately to multiple cellular targets. Noncovalent interactions allow drugs to selectively modify target cell activity while leaving other cells unaffected, making reversibility a key feature of safe, effective therapeutics.